Thursday’s weakness in Cytokinetics’ (CYTK) shares is likely due to commentary from Bristol Myers’ (BMY) earnings call, where the company ...

TransCode Therapeutics (RNAZ) announced that Cohort 3 of its Phase 1 clinical trial enrolled three patients and all have been dosed with ...

VIQ Solutions ( ($TSE:VQS) ) has issued an announcement. VIQ Solutions has announced a strategic review process to explore alternatives for ...

Cartier Resources Inc. has announced a change in its senior leadership as part of a new development strategy, with Mr. Gaétan Lavallière stepping down as Vice-President. The com ...

PepsiCo Inc. (PEP) released a mixed quarterly report for investors. Positive Points: → Earnings per share of $1.96 exceeded ...

The current Q4 earnings season could be filled with anxiety for Amazon (AMZN) investors. With shares trading close to their all-time highs, and with Amazon having something of an inflection point ...

Paramount’s place in the streaming sector is being tested by price hikes. Read why PARA stock may face challenges amid growing competition and market concerns.

Roth MKM analyst John White raised the firm’s price target on Vitesse Energy (VTS) to $30.50 from $27.75 and keeps a Buy rating on the shares ahead of its Q4 results. The firm is adjusting its ...

SoFi Technologies cannot afford to underwhelm, and its less robust guidance hasn't been taken too kindly by the market. Learn ...

The top contenders for the best TipRanks alternatives are Benzinga Pro, TradingView and Interactive Brokers. Looking to up your stock game without using TipRanks? We’ve got you covered.

Tip Ranks offers the standard free screening methodology, along with a focus on consensus ratings and price targets that can ...

In “The Age of Choice,” Sophia Rosenfeld questions whether choosing — what to buy, whom to vote for — is actually worth it. By Stephen Greenblatt In Anne Tyler’s new novel, a socially ...